BioCentury
ARTICLE | Clinical News

ImmunoVaccine Technologies preclinical data

October 6, 2008 7:00 AM UTC

DepoVax avian influenza virus vaccine, which uses a recombinant H5 antigen, induced antibody titers 10-15 times higher than the alum-based, control vaccine. DepoVax's depot formulation enables deliver...